Surgical Treatment of Metastatic Spinal Tumor.
- Author:
Ji Soo JANG
1
;
Jin Kuk KIM
;
Woo Min PARK
;
Yoo HEON
;
Chang Hoon RHEE
;
Seung Hoon LEE
Author Information
1. Department of Neurosurgery, Korea Cancer Canter Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Metastatic spinal tumor;
Anterior approach;
Posterior approach;
Combined anterior-posterior approach;
Embolization
- MeSH:
Angiography;
Carcinoma, Hepatocellular;
Dacarbazine;
Hemorrhage;
Humans;
Life Expectancy;
Neoplasm Metastasis;
Pneumonia;
Thoracotomy;
Thyroid Neoplasms
- From:Journal of Korean Neurosurgical Society
1999;28(10):1491-1497
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The authors present a series of 35 patients who underwent operation for metastatic spinal tumor. Patients were operated via anterior, posterior or posterolateral and combined anterior-posterior approach. The anterior approach was used in cases where there was no involvement of the posterior column, tolerable of a thoracotomy and involvement of three or less adjacent vertebral bodies. The posterior or posterolateral approach was used in cases with involvement of the posterior column, disease at two seperated locations, intolerable of a thoracotomy and involvement of three columns. The combined anterior-posterior approach was used when it was not enough to obtain stabilization with anterior or posterior approach alone and expected greater than 1 year life expectancy. Twenty-five(89%) of the 28 patients improved neurologically following surgery. Average neurologic improvement was 1.3 Frankel grade. Pain relief was obtained in twenty-six(93%) of the 28 patients. Recovery of spincter change was obtained twelve(80%) of the 15 patients. Two patients died postoperatively due to DIC and pneumonia. Prior to operation, selective spinal angiography and embolization were performed in nine patients with metastases from renal carcinoma, thyroid cancer and hepatoma to reduce intraoperative bleeding. The authors believe that the choice of surgical approach has to be individualized for each patient depending on extent and location of the tumor, general condition of patient, goal of therapy and life expectancy.
